As of market creation, Eli Lilly is estimated to release earnings on October 29, 2026. The Street consensus estimate for Eli Lilly’s non-GAAP EPS for the relevant quarter is $7.49 as of market creation. This market will resolve to "Yes" if Eli Lilly reports non-GAAP EPS greater than $7.49 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents.